Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

BUY
$2.36 - $3.35 $472 - $670
200 New
200 $0
Q2 2021

Aug 04, 2021

SELL
$13.68 - $22.34 $6,840 - $11,170
-500 Reduced 3.45%
14,000 $83,000
Q1 2021

Apr 30, 2021

BUY
$9.0 - $63.91 $112,500 - $798,875
12,500 Added 625.0%
14,500 $155,000
Q4 2020

Jan 29, 2021

SELL
$4.82 - $10.1 $9,640 - $20,200
-2,000 Reduced 50.0%
2,000 $3,000
Q3 2020

Nov 05, 2020

BUY
$4.7 - $8.7 $2,820 - $5,220
600 Added 17.65%
4,000 $1,000
Q2 2020

Jul 23, 2020

SELL
$5.54 - $10.81 $22,714 - $44,321
-4,100 Reduced 54.67%
3,400 $1,000
Q1 2020

May 05, 2020

BUY
$2.47 - $21.36 $17,290 - $149,520
7,000 Added 1400.0%
7,500 $2,000
Q1 2019

Apr 24, 2019

BUY
$64.85 - $100.15 $32,424 - $50,075
500 New
500 $1,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $905M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.